Label-free in vitro assays predict the potency of anti-disialoganglioside chimeric antigen receptor T-cell products-Reference-Cited by-同舟云学术

Label-free in vitro assays predict the potency of anti-disialoganglioside chimeric antigen receptor T-cell products

Published:2023-06 Issue:6 Volume:25 Page:670-682
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Logun Meghan,Colonna Maxwell B.^ORCID,Mueller Katherine P.,Ventarapragada Divya,Rodier Riley^ORCID,Tondepu Chaitanya,Piscopo Nicole J.,Das Amritava,Chvatal Stacie,Hayes Heather B.,Capitini Christian M.^ORCID,Brat Daniel J.,Kotanchek Theresa^ORCID,Edison Arthur S.^ORCID,Saha Krishanu^ORCID,Karumbaiah Lohitash

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference78 articles.

1. Chimeric antigen receptor T cell therapy: 25years in the making;Gill;Blood Rev.,2016

2. CART immunotherapy: development, success, and translation to malignant gliomas and other solid tumors;Filley;Front. Oncol.,2018

3. Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward;Li;J. Hematol. Oncol.,2018

4. Chimeric antigen receptor T-cell therapy for solid tumors;Newick;Mol Ther Oncolytics,2016

5. CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges;Bagley;Neuro. Oncol.,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy;Frontiers in Molecular Medicine;2024-02-01

2. In vitro encapsulation and expansion of T and CAR-T cells using 3D synthetic thermo-responsive matrices;RSC Advances;2024